Blog: Patient Insights & Thought Leadership

Healthcare Industry Thought Leadership

Health Union’s data-driven industry conversations help pharma make smarter, more effective decisions.
Check out our latest thought leadership pieces below.

Differences in DMT treatment experiences among people with MS: Here’s what patients say

July 30, 2018

For many people living with multiple sclerosis (MS), treatment decisions can often be nuanced and complicated. In April of 2018, the American Academy of Neurology (AAN) released new guidelines about when to begin, change, and end disease-modifying therapies (DMTs) for MS patients. MS In America 2018 results may help the healthcare industry gain a broader understanding of people’s experiences, or lack thereof, with DMTs and other MS treatment options.

WHITEPAPER DOWNLOAD: #authenticity How Social Media Can Fuel Growth-Oriented, Sustainable Online Communities

June 28, 2018

Download the full free whitepaper, "#authenticity How Social Media Can Fuel Growth-Oriented, Sustainable Online Communities"

Expanding Patient Voices and Understanding Their Perspectives

Patient Centricity Starts With Patients: Closing the Trial Recruitment Gap

June 27, 2018

There is a lot of talk in the industry about patient centricity, but is it the reality? We talk about putting the needs of patients first and keeping them central in the business decisions we make across the healthcare industry. However, as we discussed on a panel at this year’s DIA 2018 Global Annual Meeting, somehow in the effort to amplify patient centricity, a critical voice is often underrepresented—the voice of the patient.

Building Relationships vs. Publishing Content: Reflecting on the Renewed Interest In Migraine Disease

June 1, 2018

A new class of migraine drugs, called anti-CGRPs (calcitonin gene-related peptide) are expected to reinvigorate a market that has been largely dormant for some time. Four biopharma companies, Amgen, Teva, Lilly and Alder are entering the fray. Not surprisingly, the intense competition and pharma investment associated with this market dynamic has led traditional “eyeball driven” publishers, like WebMD, Everyday Health and others on a quest to offer substantially more migraine-related content in reaction to this market opportunity.

Nothing About Me, Without Me: How Biopharma Can Play a Role in Shared Decision Making

April 25, 2018

Imagine buying a house without seeing it in person, and without knowing the price or monthly payments. Imagine taking a job without knowing the people, your responsibilities or your salary. Going blind into these momentous decisions without any additional information would be terrifying.

People With Parkinson’s Disease Are Turning to the Web to Manage Their Condition

April 24, 2018

“Parkinson’s Disease In America 2018,” an annual survey conducted by Health Union, recently revealed the experiences and perspectives of more than 1,600 patients and care partners who are impacted by PD. The survey shows patients turned to PD-specific websites nearly as much as their doctor to learn about or manage their condition.

WHITEPAPER DOWNLOAD: Seeing Shared Decision Making Through the Lens of the Cancer Patient

April 20, 2018

Download our full free whitepaper, “Seeing Shared Decision Making Through the Lens of the Cancer Patient.”

Let’s Talk About IBS: What people with IBS want others to know

April 16, 2018

IBS can cause gastrointestinal symptoms that have a substantial negative impact on one’s life, which is often amplified by the condition’s impact on a patient’s emotional well-being. The “IBS In America 2018” survey conducted by Health Union gathered insights from over 1,500 people currently suffering from IBS to better understand the condition’s impact on their lives. The survey found that 45% of people with IBS are apt to experience anxiety or panic disorders, with stress also being a trigger for many patients.

Healthcare Industry Thought Leadership

Contact